1.Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, et al. Exosome processing and characterization approaches for research and technology development. Advanced Science. 2022;9(15):2103222.
2.Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R, et al. Review on strategies and technologies for exosome isolation and purification. Frontiers in bioengineering and biotechnology. 2022;9:811971.
3.Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789.
4.Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cellular and Molecular Life Sciences. 2018;75:193-208.
5.Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684.
6.Decramer S, de Peredo AG, Breuil B, Mischak H, Monsarrat B, Bascands J-L, et al. Urine in clinical proteomics. Molecular & cellular proteomics. 2008;7(10):1850-62.
7.Street J, Koritzinsky E, Glispie D, Star R, Yuen P. Urine exosomes: an emerging trove of biomarkers. Advances in clinical chemistry. 2017;78:103-22.
8.Wang Y, Zhang M. Urinary exosomes: A promising biomarker for disease diagnosis. Laboratory Medicine. 2023;54(2):115-25.
9.Lee N, Canagasingham A, Bajaj M, Shanmugasundaram R, Hutton A, Bucci J, et al. Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: from functional roles to clinical significance. Frontiers in Oncology. 2022;12:1019391.
10.El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, et al. Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection. Journal of the American Society of Nephrology. 2021;32(4):994-1004.
11.Street JM, Koritzinsky EH, Glispie DM, Yuen PS. Urine exosome isolation and characterization. Drug Safety Evaluation: Methods and Protocols. 2017:413-23.
12.Dimov I, Jankovic Velickovic L, Stefanovic V. Urinary exosomes. The Scientific World Journal. 2009;9(1):1107-18.
13.Mizutani K, Kawakami K, Horie K, Fujita Y, Kameyama K, Kato T, et al. Urinary exosome as a potential biomarker for urinary tract infection. Cellular microbiology. 2019;21(7):e13020.
14.Gonzales PA, Zhou H, Pisitkun T, Wang NS, Star RA, Knepper MA, et al. Isolation and purification of exosomes in urine. The Urinary Proteome: Methods and Protocols. 2010:89-99.
15.Cao Y, Shi Y, Yang Y, Wu Z, Peng N, Xiao J, et al. Urinary exosomes derived circRNAs as biomarkers for chronic renal fibrosis. Annals of Medicine. 2022;54(1):1966-76.
16.Blijdorp CJ, Tutakhel OA, Hartjes TA, van den Bosch TP, van Heugten MH, Rigalli JP, et al. Comparing approaches to normalize, quantify, and characterize urinary extracellular vesicles. Journal of the American Society of Nephrology. 2021;32(5):1210-26.
17.Xiang X, Guan F, Jiao F, Li H, Zhang W, Zhang Y, et al. A new urinary exosome enrichment method by a combination of ultrafiltration and TiO 2 nanoparticles. Analytical Methods. 2021;13(13):1591-600.
18.Lee H, Kang SJ, Lee J, Park KH, Rhee WJ. Isolation and characterization of urinary extracellular vesicles from healthy donors and patients with castration-resistant prostate cancer. International Journal of Molecular Sciences. 2022;23(13):7134.
19.Deng F, Miller J. A review on protein markers of exosome from different bio-resources and the antibodies used for characterization. Journal of Histotechnology. 2019;42(4):226-39.
20.Gheinani AH, Vögeli M, Baumgartner U, Vassella E, Draeger A, Burkhard FC, et al. Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Scientific reports. 2018;8(1):3945.
21.Asvapromtada S, Sonoda H, Kinouchi M, Oshikawa S, Takahashi S, Hoshino Y, et al. Characterization of urinary exosomal release of aquaporin-1 and-2 after renal ischemia-reperfusion in rats. American Journal of Physiology-Renal Physiology. 2018;314(4):F584-F601.
22.Zhang M, Jin K, Gao L, Zhang Z, Li F, Zhou F, et al. Methods and technologies for exosome isolation and characterization. Small Methods. 2018;2(9):1800021.
23.Ludwig N, Whiteside TL, Reichert TE. Challenges in exosome isolation and analysis in health and disease. International journal of molecular sciences. 2019;20(19):4684.
24.Yakubovich E, Polischouk A, Evtushenko V. Principles and problems of exosome isolation from biological fluids. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology. 2022;16(2):115-26.
25.Liu W-z, Ma Z-j, Kang X-w. Current status and outlook of advances in exosome isolation. Analytical and Bioanalytical Chemistry. 2022;414(24):7123-41.
26.Soares Martins T, Catita J, Martins Rosa I, AB da Cruz e Silva O, Henriques AG. Exosome isolation from distinct biofluids using precipitation and column-based approaches. PloS one. 2018;13(6):e0198820.
27.Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia‐Perez JE, et al. Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses. Current protocols in cell biology. 2020;88(1):e110.
28.Xu K, Jin Y, Li Y, Huang Y, Zhao R. Recent progress of exosome isolation and peptide recognition-guided strategies for exosome research. Frontiers in Chemistry. 2022;10:844124.
29.Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? International journal of molecular sciences. 2020;21(18):6466.
30.Stranska R, Gysbrechts L, Wouters J, Vermeersch P, Bloch K, Dierickx D, et al. Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. Journal of translational medicine. 2018;16:1-9.
31.Navajas R, Corrales FJ, Paradela A. Serum exosome isolation by size-exclusion chromatography for the discovery and validation of preeclampsia-associated biomarkers. Proteomics for Biomarker Discovery: Methods and Protocols. 2019:39-50.
32.Le M-CN, Fan ZH. Exosome isolation using nanostructures and microfluidic devices. Biomedical Materials. 2021;16(2):022005.
33.Wang J, Ma P, Kim DH, Liu B-F, Demirci U. Towards microfluidic-based exosome isolation and detection for tumor therapy. Nano Today. 2021;37:101066.
34.Shen J, Ma Z, Xu J, Xue T, Lv X, Zhu G, et al. Exosome isolation and detection: from microfluidic chips to nanoplasmonic biosensor. ACS Applied Materials & Interfaces. 2024;16(18):22776-93.
35.Liu J, Zhijin Z, Zhang W, Niraj M, Yang F, Changcheng G, et al. Urinary exosomes: Potential diagnostic markers and application in bladder cancer. Heliyon. 2024;10(12).
36.Song Q, Yu H, Han J, Lv J, Lv Q, Yang H. Exosomes in urological diseases-Biological functions and clinical applications. Cancer Letters. 2022;544:215809.
37.Gang D, Yu CJ, Zhu S, Zhu P, Nasser M. Application of mesenchymal stem cell-derived exosomes in kidney diseases. Cellular Immunology. 2021;364:104358.
38.Qin Z, Hu H, Sun W, Chen L, Jin S, Xu Q, et al. miR-224-5p contained in urinary extracellular vesicles regulates PD-L1 expression by inhibiting cyclin D1 in renal cell carcinoma cells. Cancers. 2021;13(4):618.
39.Sharma S, Rana R, Prakash P, Ganguly NK. Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. Molecular and Cellular Biochemistry. 2024;479(1):127-70.
40.    Wen J, Yang T, Mallouk N, Zhang Y, Li H, Lambert C, et al. Urinary exosomal CA9 mRNA as a novel liquid biopsy for molecular diagnosis of bladder cancer. International Journal of Nanomedicine. 2021:4805-11.
41.Rajput A, Varshney A, Bajaj R, Pokharkar V. Exosomes as new generation vehicles for drug delivery: biomedical applications and future perspectives. Molecules. 2022;27(21):7289.
42.Guo ZY, Tang Y, Cheng YC. Exosomes as targeted delivery drug system: advances in exosome loading, surface functionalization and potential for clinical application. Current Drug Delivery. 2024;21(4):473-87.
43.Vitorino R, Ferreira R, Guedes S, Amado F, Thongboonkerd V. What can urinary exosomes tell us? Cellular and Molecular Life Sciences. 2021;78:3265-83.
44.Hiltbrunner S, Mints M, Eldh M, Rosenblatt R, Holmström B, Alamdari F, et al. Urinary exosomes from bladder cancer patients show a residual cancer phenotype despite complete pathological downstaging. Scientific reports. 2020;10(1):5960.
45.Beckham CJ, Olsen J, Yin P-N, Wu C-H, Ting H-J, Hagen FK, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. The Journal of urology. 2014;192(2):583-92.
46.Elsharkawi F, Elsabah M, Shabayek M, Khaled H. Urine and serum exosomes as novel biomarkers in detection of bladder cancer. Asian Pacific journal of cancer prevention: APJCP. 2019;20(7):2219.
47.Yazarlou F, Modarressi MH, Mowla SJ, Oskooei VK, Motevaseli E, Tooli LF, et al. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer management and research. 2018:6357-65.
48.Wei X, Cai L, Chen H, Shang L, Zhao Y, Sun W. Noninvasive multiplexed analysis of bladder cancer-derived urine exosomes via janus magnetic microspheres. Analytical Chemistry. 2022;94(51):18034-41.
49.Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, et al. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget. 2015;6(30):30357.
50.Long C, Shi H, Li J, Chen L, Lv M, Tai W, et al. The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 2024;22(1):285.
51.Wang Y-T, Shi T, Srivastava S, Kagan J, Liu T, Rodland KD. Proteomic analysis of exosomes for discovery of protein biomarkers for prostate and bladder cancer. Cancers. 2020;12(9):2335.
52.Geng H, Zhou Q, Guo W, Lu L, Bi L, Wang Y, et al. Exosomes in bladder cancer: novel biomarkers and targets. Journal of Zhejiang University-SCIENCE B. 2021;22(5):341-7.
53.Wang X, Song D, Zhu B, Jin Y, Cai C, Wang Z. Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer. Anti-Cancer Drugs. 2024;35(4):362-70.
54.Zhu Q, Cheng L, Deng C, Huang L, Li J, Wang Y, et al. The genetic source tracking of human urinary exosomes. Proceedings of the National Academy of Sciences. 2021;118(43):e2108876118.
55.Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. BioMed research international. 2014;2014(1):619829.
56.Leiblich A. Recent developments in the search for urinary biomarkers in bladder cancer. Current urology reports. 2017;18:1-6.
57.Panfoli I. Cancer exosomes in urine: a promising biomarker source. Translational cancer research. 2017;6(Suppl 8).
58.Huda MN, Nurunnabi M. Potential application of exosomes in vaccine development and delivery. Pharmaceutical Research. 2022;39(11):2635-71.
59.Tan D, Li G, Fu W, Lei C. Exosomes: The next frontier in vaccine development and delivery. Frontiers in Immunology. 2024;15:1435426.
60.El Safadi D, Mokhtari A, Krejbich M, Lagrave A, Hirigoyen U, Lebeau G, et al. Exosome-mediated antigen delivery: unveiling novel strategies in viral infection control and vaccine design. Vaccines. 2024;12(3):280.
61.Pordanjani PM, Bolhassani A, Milani A, Pouriayevali MH. Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases. Process Biochemistry. 2023;128:167-80.
62.Behzadi P, Kim C-H, Pawlak EA, Algammal A. The innate and adaptive immune system in human urinary system. Frontiers Media SA; 2023. p. 1294869.
63.Seo J-W, Lee YH, Tae DH, Kim YG, Moon J-Y, Jung SW, et al. Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients. Frontiers in immunology. 2023;14:1190576.
64.Santos P, Almeida F. Exosome-based vaccines: history, current state, and clinical trials. Frontiers in Immunology. 2021;12:711565.
65.Dhar R, Bhattacharya B, Mandal D, Devi A, Thorat ND. Exosome-based cancer vaccine: A cutting-edge approach–Correspondence. International journal of surgery. 2022;108:106993.
66.Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Communication and Signaling. 2022;20(1):145.
67.Yang M, Wu SY. The advances and challenges in utilizing exosomes for delivering cancer therapeutics. Frontiers in pharmacology. 2018;9:735.
68.Yamashita T, Takahashi Y, Takakura Y. Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biological and Pharmaceutical Bulletin. 2018;41(6):835-42.
69.Li X, Corbett AL, Taatizadeh E, Tasnim N, Little JP, Garnis C, et al. Challenges and opportunities in exosome research—Perspectives from biology, engineering, and cancer therapy. APL bioengineering. 2019;3(1).
70.Yu W, Hurley J, Roberts D, Chakrabortty S, Enderle D, Noerholm M, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges. Annals of Oncology. 2021;32(4):466-77.
71.Syn NL, Wang L, Chow EK-H, Lim CT, Goh B-C. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends in biotechnology. 2017;35(7):665-76.
72.Rezabakhsh A, Sokullu E, Rahbarghazi R. Applications, challenges and prospects of mesenchymal stem cell exosomes in regenerative medicine. Stem Cell Research & Therapy. 2021;12:1-8.
73.Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica B. 2016;6(4):287-96.